Dr. Velaphi Thipe
Biography

Scientific Profile.

I am a Postdoctoral Research Fellow in the Department of Radiology at the University of Missouri School of Medicine, affiliated with the Institute of Green Nanotechnology. Originally from South Africa, I earned my bachelor’s degree in Biotechnology and a master’s degree in Nanoscience from the University of Johannesburg. I was subsequently awarded the prestigious Fulbright Program scholarship to pursue my Ph.D. in the United States at the University of Missouri–Columbia, a global leader in radiopharmaceutical science and home to the University of Missouri Research Reactor (MURR), one of the most powerful university-based nuclear reactors in the world.

Under the mentorship of Professor Kattesh V. Katti, internationally recognized as the Father of Green Nanotechnology, I completed my doctoral training at the intersection of nanomedicine, radiochemistry, and cancer biology. In parallel, I earned a Master of Business Administration (MBA) with a focus on Life Sciences, Innovation, and Entrepreneurship from the Robert J. Trulaske, Sr. College of Business at the University of Missouri. This dual scientific and business training enables me to align advanced research with global health priorities, translate discoveries into real-world applications, and navigate commercialization, partnerships, and stakeholder ecosystems with strategic foresight.

My research career is defined by international collaboration and translational impact. I previously served as a Postdoctoral Fellow at the Nuclear and Energy Research Institute (IPEN) in São Paulo, Brazil, supported by the São Paulo Research Foundation (FAPESP). At IPEN—Latin America’s premier nuclear science institution—I conducted research on smart immunotherapeutic gold and palladium nanoparticles within the Center for Chemical and Environmental Technology (CQMA), under the mentorship of Professor Ademar B Lugão.

"During this period, I contributed to the development and manufacturing of bioactive heat-and-moisture exchanger (HME) filters... resulting in a U.S. patent and a commercial product, YOUFILTER Ag®."

My professional trajectory across South Africa, the United States, and Brazil has given me a rare vantage point: combining the ingenuity required in resource-constrained environments with access to high-end nuclear, biomedical, and translational research infrastructure. I continue to serve as a consultant to the University of Pretoria and the University of Johannesburg, ensuring that knowledge transfer and capacity building remain central to my work. To date, my scholarly output has accumulated over 1,450 citations, reflecting sustained contributions at the intersection of green chemistry, nanomedicine, and cancer biology.

As a principal investigator, I have led highly interdisciplinary research teams comprising trainees from South Africa, Brazil, India, Thailand, France, and the United States. My work emphasizes methodological rigor, translational relevance, and global accessibility, laying the foundation for innovative nanophytomedicines. In recognition of my scientific contributions, I was selected as one of only 635 young scientists worldwide to participate in the 72nd Lindau Nobel Laureate Meeting, dedicated to Physiology and Medicine.

Innovation & Patents

A defining feature of my career is the translation of research discoveries into value-added products. I am a key inventor on multiple patents with active commercial outcomes. Among these is Systems and Methods for Small Molecule Encapsulation (US20250205162A1, pending), developed in collaboration with Tecton Life. This invention has already resulted in FDA-acknowledged products with a New Dietary Ingredient (NDI) designation.

Research Interests

Green synthesis of immunodulatory nanoparticles for targeted prostate cancer therapy
Scientific validation of Ayurvedic medicines through Nano-Ayurvedic Medicine
Immunomodulatory nanotechnologies for cancer therapy
Nanotechnology-based solutions for food security and mycotoxin mitigation

A central achievement of my work is the development of immunomodulatory nanoparticles capable of reprogramming pro-tumor (M2) macrophages into anti-tumor (M1) phenotypes, opening new frontiers in cancer immunotherapy.

Selected Work

Resveratrol-Functionalized Gold Nanoparticles Mechanism

Resveratrol-Functionalized Gold Nanoparticles

I co-developed a resveratrol-198Au nanocomposite that delivers radioactive gold directly to prostate tumors. This green nanomedicine platform demonstrates high serum stability and achieves significantly reduced tumor volume in preclinical models.

Palladium Nanoparticles Immunomodulation Mechanism

Palladium Nanoparticles for Immunomodulation

Using a zero-carbon-emission synthesis process, my team developed resveratrol-derived palladium nanoparticles (Res-PdNPs) that reprogram tumor-supportive macrophages into tumor-fighting immune cells.

Acknowledgements

"I gratefully acknowledge the organizations and institutions whose financial support and collaborative environments have made my research possible."

Reid & MitchellNRFNano ScienceFulbrightFAPESP